FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

20532711000001101: Neisseria meningitidis group A capsular polysaccharide protein conjugate (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 30-May 2012. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
69118801000001118 Neisseria meningitidis group A capsular polysaccharide protein conjugate (substance) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
69118901000001112 Neisseria meningitidis group A capsular polysaccharide protein conjugate en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Neisseria meningitidis group A capsular polysaccharide protein conjugate Is a Antigen of Neisseria meningitidis true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Meningococcal polysaccharide A, C, W135 and Y conjugate vaccine powder and solvent for solution for injection 0.5ml vials Has specific active ingredient True Neisseria meningitidis group A capsular polysaccharide protein conjugate Inferred relationship Existential restriction modifier
ACWY Vax powder and solvent for solution for injection 0.5ml vials (GlaxoSmithKline) Has specific active ingredient True Neisseria meningitidis group A capsular polysaccharide protein conjugate Inferred relationship Existential restriction modifier
Meningococcal polysaccharide A, C, W135 and Y conjugate vaccine powder and solvent for solution for injection 0.5ml vials 1 vial Has specific active ingredient True Neisseria meningitidis group A capsular polysaccharide protein conjugate Inferred relationship Existential restriction modifier
ACWY Vax powder and solvent for solution for injection 0.5ml vials (GlaxoSmithKline) 1 vial Has specific active ingredient True Neisseria meningitidis group A capsular polysaccharide protein conjugate Inferred relationship Existential restriction modifier
Meningococcal polysaccharide A, C, W135 and Y conjugate vaccine solution for injection 0.5ml vials Has specific active ingredient True Neisseria meningitidis group A capsular polysaccharide protein conjugate Inferred relationship Existential restriction modifier
MenQuadfi vaccine solution for injection 0.5ml vials (Sanofi Pasteur) 1 vial Has specific active ingredient True Neisseria meningitidis group A capsular polysaccharide protein conjugate Inferred relationship Existential restriction modifier
MenQuadfi vaccine solution for injection 0.5ml vials (Sanofi Pasteur) Has specific active ingredient True Neisseria meningitidis group A capsular polysaccharide protein conjugate Inferred relationship Existential restriction modifier
Meningococcal polysaccharide A, C, W135 and Y conjugate vaccine solution for injection 0.5ml vials 1 vial Has specific active ingredient True Neisseria meningitidis group A capsular polysaccharide protein conjugate Inferred relationship Existential restriction modifier
Meningococcal polysaccharide A, C, W135 and Y conjugate vaccine powder and solvent for solution for injection 0.5ml pre-filled syringes Has specific active ingredient True Neisseria meningitidis group A capsular polysaccharide protein conjugate Inferred relationship Existential restriction modifier
Nimenrix vaccine powder and solvent for solution for injection 0.5ml pre-filled syringes (GlaxoSmithKline UK Ltd) Has specific active ingredient True Neisseria meningitidis group A capsular polysaccharide protein conjugate Inferred relationship Existential restriction modifier
Meningococcal polysaccharide A, C, W135 and Y conjugate vaccine powder and solvent for solution for injection 0.5ml pre-filled syringes 1 pre-filled disposable injection Has specific active ingredient True Neisseria meningitidis group A capsular polysaccharide protein conjugate Inferred relationship Existential restriction modifier
Nimenrix vaccine powder and solvent for solution for injection 0.5ml pre-filled syringes (GlaxoSmithKline UK Ltd) 1 pre-filled disposable injection Has specific active ingredient True Neisseria meningitidis group A capsular polysaccharide protein conjugate Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start